Solventum (SOLV) Liabilities and Shareholders Equity (2023 - 2026)
Solventum (SOLV) posted Liabilities and Shareholders Equity of $14.1 billion for Q1 2026, down 1.38% on a QoQ basis from $14.3 billion in Q4 2025, and down 2.96% year-over-year from $14.5 billion in Q1 2025.
Solventum (SOLV) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
Solventum's Liabilities and Shareholders Equity history runs 4 years deep, the most recent figure standing at $14.1 billion for Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 2.96% year-over-year to $14.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.4 billion (down 1.49% YoY) and the FY2025 annual result came in at $14.3 billion, down 1.13% from the prior year.
- Liabilities and Shareholders Equity was $14.1 billion for Q1 2026 at Solventum, down from $14.3 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $15.1 billion in Q2 2025 and bottomed at $13.9 billion in Q4 2023.
- A 4-year average of $14.4 billion and a median of $14.5 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity climbed 3.69% — and 2025, when it retreated 5.24%.
- Solventum's Liabilities and Shareholders Equity stood at $13.9 billion in 2023, then increased by 3.69% to $14.5 billion in 2024, then fell by 1.13% to $14.3 billion in 2025, then decreased by 1.38% to $14.1 billion in 2026.
- Business Quant data shows SOLV's Liabilities and Shareholders Equity at $14.1 billion in Q1 2026, $14.3 billion in Q4 2025, and $14.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 31.62 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 50.83 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 39.01 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 8.78 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 14.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.31 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 19.85 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.10 Bn |
| Dec 31, 2025 | 14.29 Bn |
| Sep 30, 2025 | 13.97 Bn |
| Jun 30, 2025 | 15.07 Bn |
| Mar 31, 2025 | 14.53 Bn |
| Dec 31, 2024 | 14.46 Bn |
| Sep 30, 2024 | 14.75 Bn |
| Jun 30, 2024 | 14.58 Bn |
| Mar 31, 2024 | 14.71 Bn |
| Dec 31, 2023 | 13.94 Bn |